C. Robert Fields

1.1k total citations
9 papers, 865 citations indexed

About

C. Robert Fields is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, C. Robert Fields has authored 9 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Nephrology. Recurrent topics in C. Robert Fields's work include Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). C. Robert Fields is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). C. Robert Fields collaborates with scholars based in United States, Hong Kong and Puerto Rico. C. Robert Fields's co-authors include Keith D. Robertson, Sheng Zhong, Tae‐You Kim, Qian Tao, Amber L. Delmas, Lingbao Ai, Kevin D. Brown, Bilian Jin, Jeong Hoon Kim and Nan Su and has published in prestigious journals such as Cancer Research, Oncogene and Human Molecular Genetics.

In The Last Decade

C. Robert Fields

9 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Robert Fields United States 8 740 175 171 93 57 9 865
Romulo Martin Brena United States 16 852 1.2× 232 1.3× 132 0.8× 120 1.3× 91 1.6× 19 1.1k
Małgorzata Jarmuż‐Szymczak Poland 18 573 0.8× 181 1.0× 151 0.9× 103 1.1× 64 1.1× 64 781
Ulrike Schwarz‐Boeger Germany 10 401 0.5× 167 1.0× 215 1.3× 172 1.8× 48 0.8× 23 739
Connie C. Cortez United States 8 857 1.2× 166 0.9× 130 0.8× 70 0.8× 98 1.7× 10 966
Emmanuel Tubacher France 8 465 0.6× 170 1.0× 131 0.8× 95 1.0× 49 0.9× 11 708
Zaletaev Dv Russia 12 435 0.6× 201 1.1× 86 0.5× 154 1.7× 79 1.4× 93 674
Masahiko Shiraishi Japan 13 466 0.6× 99 0.6× 120 0.7× 94 1.0× 37 0.6× 39 607
Timothée Revil Canada 13 878 1.2× 172 1.0× 81 0.5× 81 0.9× 64 1.1× 19 1.0k
Maija Lepistö Finland 8 261 0.4× 162 0.9× 101 0.6× 76 0.8× 49 0.9× 15 523
Jean‐François Laes Belgium 12 317 0.4× 218 1.2× 136 0.8× 146 1.6× 114 2.0× 26 692

Countries citing papers authored by C. Robert Fields

Since Specialization
Citations

This map shows the geographic impact of C. Robert Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Robert Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Robert Fields more than expected).

Fields of papers citing papers by C. Robert Fields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Robert Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Robert Fields. The network helps show where C. Robert Fields may publish in the future.

Co-authorship network of co-authors of C. Robert Fields

This figure shows the co-authorship network connecting the top 25 collaborators of C. Robert Fields. A scholar is included among the top collaborators of C. Robert Fields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Robert Fields. C. Robert Fields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jin, Bilian, Bing Yao, Jian‐Liang Li, et al.. (2009). DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer. Cancer Research. 69(18). 7412–7421. 90 indexed citations
2.
Gopalakrishnan, Suhasni, Beth O. Van Emburgh, Jixiu Shan, et al.. (2009). A Novel DNMT3B Splice Variant Expressed in Tumor and Pluripotent Cells Modulates Genomic DNA Methylation Patterns and Displays Altered DNA Binding. Molecular Cancer Research. 7(10). 1622–1634. 77 indexed citations
3.
Qiu, Jingxin, Lingbao Ai, Cheppail Ramachandran, et al.. (2008). Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas. Laboratory Investigation. 88(9). 910–925. 48 indexed citations
5.
Kim, Tae‐You, Sheng Zhong, C. Robert Fields, Jeong Hoon Kim, & Keith D. Robertson. (2006). Epigenomic Profiling Reveals Novel and Frequent Targets of Aberrant DNA Methylation-Mediated Silencing in Malignant Glioma. Cancer Research. 66(15). 7490–7501. 141 indexed citations
6.
Ai, Lingbao, Tae‐You Kim, C. Robert Fields, et al.. (2006). Epigenetic Silencing of the Tumor Suppressor Cystatin M Occurs during Breast Cancer Progression. Cancer Research. 66(16). 7899–7909. 71 indexed citations
7.
Ai, Lingbao, Qian Tao, Sheng Zhong, et al.. (2006). Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 27(7). 1341–1348. 154 indexed citations
8.
Zhong, Sheng, C. Robert Fields, Nan Su, Yuan‐Xiang Pan, & Keith D. Robertson. (2006). Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Oncogene. 26(18). 2621–2634. 101 indexed citations
9.
Ferdig, Richard E., et al.. (2003). Thoughtful Creation of Online Course Content: Implications of SCORM for Educators. Academic exchange quarterly. 7(1). 158–163. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026